These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 17188887

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis.
    Bristow RE, Santillan A, Salani R, Diaz-Montes TP, Giuntoli RL, Meisner BC, Armstrong DK, Frick KD.
    Gynecol Oncol; 2007 Sep; 106(3):476-81. PubMed ID: 17688927
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
    Berry E, Matthews KS, Singh DK, Buttin BM, Lurain JR, Alvarez RD, Schink J.
    Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer.
    Naumann RW, Sukumvanich P, Edwards RP.
    Gynecol Oncol; 2009 Jul; 114(1):37-41. PubMed ID: 19410281
    [Abstract] [Full Text] [Related]

  • 13. [Latest information in the diagnoses of ovarian carcinoma].
    Isonishi S.
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1351-7. PubMed ID: 12214460
    [Abstract] [Full Text] [Related]

  • 14. Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survival.
    Alberts DS, Marth C, Alvarez RD, Johnson G, Bidzinski M, Kardatzke DR, Bradford WZ, Loutit J, Kirn DH, Clouser MC, Markman M, GRACES Clinical Trial Consortium.
    Gynecol Oncol; 2008 May; 109(2):174-81. PubMed ID: 18314182
    [Abstract] [Full Text] [Related]

  • 15. Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option.
    Fiorentini G, Filippeschi M, Turrisi G, Mambrini A, Giannessi PG, D'Alessandro M, Rossi S, Dentico P, Guadagni S, Cantore M, Madrigali A.
    In Vivo; 2009 May; 23(2):317-21. PubMed ID: 19414421
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chemotherapy of advanced ovarian cancer: current status and future directions.
    Ozols RF, Vermorken JB.
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-1-S2-9. PubMed ID: 9045324
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. ACOG Committee Opinion No. 396. Intraperitoneal chemotherapy for ovarian cancer.
    American College of Obstetricians and Gynecologists.
    Obstet Gynecol; 2008 Jan; 111(1):249. PubMed ID: 18165421
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.